← Evidence map

ArticleThe Journal of antimicrobial chemotherapy2026

Antimicrobial activity of aztreonam/avibactam and molecular characterization of Enterobacterales not susceptible to ceftazidime/avibactam and/or meropenem/vaborbactam from US medical centres (2016-2024).

Helio S Sader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Antimicrobial activity of aztreonam/avibactam and molecular characterization of Enterobacterales not susceptible to ceftazidime/avibactam and/or meropenem/vaborbactam from US medical centres (2016-2024). | OpenQuestion